Performance of Semiquantitative and Quantitative D-Dimer Assays in the ECAT External Quality Assessment Program

 

 Buy Article Permissions and Reprints

ABSTRACT

D-dimer levels are used in clinical practice as markers for the presence or exclusion of venous thrombosis. Therefore, it is important that the performance of the D-dimer tests is well controlled.

One of the components of a laboratory quality program is external quality assessment (EQA). The main aim of EQA is to identify the degree of agreement among laboratories. In addition to identifying the individual laboratory performance, it also identifies the characteristics of the different reagents and methods that are used in different laboratories. Recently, the D-dimer test was included in the ECAT External Quality Assessment program.

Eighty-one laboratories in four rounds applied semiquantitative and quantitative D-dimer assays to three samples (concentrations normal, slightly elevated, and elevated). Although the reported values varied widely, the classification of the samples was mostly correct for the normal and the elevated samples. The slightly elevated sample was classified as normal by all laboratories using semiquantitative methods and by 60% of the laboratories using quantitative methods, and this varied between 45% and 86% for the different methods.

In conclusion, D-dimer methods show a large variation, and the quality of the D-dimer assessment could be improved by standardization and by using cut-off ranges.

REFERENCES

• 1 Bounameaux H, Slosman D, de Moerloose P, Reber G. Diagnostic value of plasma D-dimer in suspected pulmonary embolism.  Lancet . 1988;  2 628-629
  PubMedGoogle Scholar
• 2 Gaffney P J, Creighton L J, Callus M, Thorpe R. Monoclonal antibodies to crosslinked fibrin degradation products (XL-FDP). II. Evaluation in a variety of clinical conditions.  Br J Haematol . 1988;  68 91-96
  PubMedGoogle Scholar
• 3 Brill-Edwards P, Lee A. D-dimer testing in the diagnosis of acute venous thromboembolism.  Thromb Haemost . 1999;  82 688-694
  PubMedGoogle Scholar
• 4 Lowe G DO, Rummley A. Use of fibrinogen and fibrin D-dimer in prediction of arterial thrombotic events.  Thromb Haemost . 1999;  82 667-672
  PubMedGoogle Scholar
• 5 Doolittle R F. Fibrinogen and fibrin.  Sci Am . 1981;  245 126-135
  PubMedGoogle Scholar
• 6 Graeff H, Hafter R. Detection and relevance of crosslinked fibrin derivatives in blood.  Semin Thromb Hemost . 1982;  8 57-68
  PubMedGoogle Scholar
• 7 Gaffney P J, Perry M J. Unreliability of current serum fibrin degradation product (FDP) assays.  Thromb Haemost . 1985;  53 301-302
  PubMedGoogle Scholar
• 8 Nieuwenhuizen W, Bos R. Soluble fibrin and degradation products of fibrinogen (FgDP), fibrin (FbDP;D-dimer) and total of FgDP and FbDP (TDP). In: Laboratory Techniques in Thrombosis. A Manual. Jespersen J, Bertina RM, Haverkate F, eds. Dordrecht: Kluwer Academic Publishers 1999: 275-284
  Google Scholar
• 9 Becker D M, Philbrick J T, Bachhuber T L, Humphries J E. D-dimer testing and acute venous thromboembolism. A shortcut to accurate diagnosis?.  Arch Intern Med . 1996;  156 939-946
  CrossrefPubMedGoogle Scholar
• 10 Lee A Y, Ginsberg J S. Laboratory diagnosis of venous thromboembolism.  Bailliere's Clin Haematol . 1998;  11 1-18
  PubMedGoogle Scholar
• 11 Nieuwenhuizen W. A reference material for harmonisation of D-dimer assays.  Thromb Haemost . 1997;  77 1031-1033
  PubMedGoogle Scholar
• 12 Bland J M, Altman D G. Statistical methods for assessing agreement between two methods of clinical measurement.  Lancet . 1986;  I 307-310
  PubMedGoogle Scholar
• 13 Janssen M CH, Wollersheim H, Verbruggen B, Novakova I RO. Rapid D-dimer assays to exclude deep venous thrombosis and pulmonary embolism: Current status and new developments.  Semin Thromb Haemost . 1998;  24 393-400
  PubMedGoogle Scholar